D. Tsavdaridis

1.1k total citations
27 papers, 722 citations indexed

About

D. Tsavdaridis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, D. Tsavdaridis has authored 27 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in D. Tsavdaridis's work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). D. Tsavdaridis is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). D. Tsavdaridis collaborates with scholars based in Greece, United States and Belgium. D. Tsavdaridis's co-authors include George Fountzilas, Dimosthenis Skarlos, P. Kosmidis, Pavlos Papakostas, Helen Gogas, Epaminontas Samantas, C. Bacoyiannis, J. Boukovinas, T. Economopoulos and Meletios Α. Dimopoulos and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Tsavdaridis

27 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Tsavdaridis Greece	12	612	358	109	109	95	27	722
Eugene Paschold United States	8	428 0.7×	347 1.0×	154 1.4×	83 0.8×	45 0.5×	12	592
Maximilian Papi Italy	13	371 0.6×	438 1.2×	153 1.4×	245 2.2×	30 0.3×	27	619
D. Ilegbodu United States	12	574 0.9×	181 0.5×	105 1.0×	162 1.5×	26 0.3×	30	711
Yunjiang Liu China	13	517 0.8×	235 0.7×	186 1.7×	188 1.7×	47 0.5×	57	813
Bernardo Amadeo Leone United States	15	325 0.5×	206 0.6×	89 0.8×	176 1.6×	38 0.4×	35	634
Sara Elena Rebuzzi Italy	15	394 0.6×	331 0.9×	117 1.1×	107 1.0×	64 0.7×	67	643
Anna Maria Mosconi Italy	13	364 0.6×	90 0.3×	140 1.3×	134 1.2×	27 0.3×	39	558
Sarah Sammons United States	16	466 0.8×	399 1.1×	119 1.1×	168 1.5×	24 0.3×	92	706
Soo Hee Kim South Korea	13	330 0.5×	286 0.8×	207 1.9×	158 1.4×	31 0.3×	37	652
I. Garassino Italy	13	271 0.4×	342 1.0×	92 0.8×	40 0.4×	51 0.5×	28	547

Countries citing papers authored by D. Tsavdaridis

Since Specialization

Citations

This map shows the geographic impact of D. Tsavdaridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Tsavdaridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Tsavdaridis more than expected).

Fields of papers citing papers by D. Tsavdaridis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Tsavdaridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Tsavdaridis. The network helps show where D. Tsavdaridis may publish in the future.

Co-authorship network of co-authors of D. Tsavdaridis

This figure shows the co-authorship network connecting the top 25 collaborators of D. Tsavdaridis. A scholar is included among the top collaborators of D. Tsavdaridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Tsavdaridis. D. Tsavdaridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stathopoulos, George P., Dimitrios T. Trafalis, J. Dimitroulis, et al.. (2012). Combination of three cytotoxic agents in small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 71(2). 413–418. 3 indexed citations

Boukovinas, Ioannis, et al.. (2008). Diagnosis of Metastatic Tumors in Cerebrospinal Fluid Samples Using Thin-Layer Cytology. Acta Cytologica. 52(3). 304–308. 11 indexed citations

Makatsoris, Thomas, Pavlos Papakostas, Haralabos P. Kalofonos, et al.. (2007). Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer. Medical Oncology. 24(3). 301–307. 4 indexed citations

Papageorgiou, Athanassios, Konstantinos Atmatzidis, Konstantinos Tsalis, et al.. (2007). Synergistic Antitumor Activity of Oxaliplatin in Combination with Gemcitabine in Pancreatic Tumor-Bearing Mice. Chemotherapy. 53(3). 153–159. 7 indexed citations

Papakostas, Pavlos, D. Tsavdaridis, P. Kosmidis, et al.. (2006). Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study. Gastric Cancer. 9(1). 26–31. 6 indexed citations

Stathopoulos, George P., et al.. (2006). Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial. Cancer Chemotherapy and Pharmacology. 58(4). 555–560. 5 indexed citations

Kalofonos, Haralabos P., Pavlos Papakostas, Gerasimos Aravantinos, et al.. (2006). A randomised phase II study comparing irinotecan (IRI) plus leucovorin (LV) and 5-fluorouracil (5FU) versus IRI-LV-5FU followed be oxaliplatin (OXA) plus LV-5FU in patients with previously untreated metastatic colorectal cancer (CRC). Journal of Clinical Oncology. 24(18_suppl). 3583–3583. 1 indexed citations

Stathopoulos, George P., et al.. (2005). Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial. British Journal of Cancer. 93(10). 1106–1111. 20 indexed citations

Stathopoulos, G., D. Tsavdaridis, N. Malamos, et al.. (2005). Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer Chemotherapy and Pharmacology. 56(5). 487–491. 18 indexed citations

10.

Andreadis, C., et al.. (2005). Significance of Immunocytochemical Expression of E-Cadherin, N-Cadherin and CD44 in Serous Effusions Using Liquid-Based Cytology. Acta Cytologica. 49(1). 11–16. 11 indexed citations

11.

Trafalis, Dimitrios T., et al.. (2005). Preclinical studies on NSC290205 aza‐steroid alkylator activity in combination with adriamycin against lymphoid leukaemia. British Journal of Haematology. 128(3). 343–350. 10 indexed citations

12.

Stathopoulos, George P., M. Veslemes, Niki Georgatou, et al.. (2004). Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Annals of Oncology. 15(7). 1048–1055. 50 indexed citations

13.

Fountzilas, George, Christos Christodoulou, D. Tsavdaridis, et al.. (2004). Paclitaxel and Gemcitabine, As First-Line Chemotherapy, Combined with Trastuzumab in Patients with Advanced Breast Cancer: A Phase II Study Conducted by the Hellenic Cooperative Oncology Group (HeCOG). Cancer Investigation. 22(5). 655–662. 21 indexed citations

14.

Tsavdaridis, D., et al.. (2004). Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) –A phase II study. Journal of Clinical Oncology. 22(14_suppl). 3712–3712. 3 indexed citations

15.

Fountzilas, George, Evangelia Razis, D. Tsavdaridis, et al.. (2003). Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group. Clinical Breast Cancer. 4(2). 120–125. 88 indexed citations

16.

Rigatos, S., et al.. (2003). Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study. Oncology Reports. 10(6). 1817–9. 17 indexed citations

17.

Gogas, Helen, Christos Papadimitriou, Haralabos P. Kalofonos, et al.. (2002). Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group. Annals of Oncology. 13(11). 1737–1742. 57 indexed citations

18.

Skarlos, Dimosthenis, E. Samantas, Evangelos Briassoulis, et al.. (2001). Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of Oncology. 12(9). 1231–1238. 85 indexed citations

19.

Fountzilas, George, D. Tsavdaridis, Anna Kalogera‐Fountzila, et al.. (2001). Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. Annals of Oncology. 12(11). 1545–1551. 61 indexed citations

20.

Fountzilas, George, J. Daniilidis, P. Kosmidis, et al.. (1991). Platinum-Based Induction Chemotherapy Followed by Radiation as Definitive Treatment for Patients with Locally Advanced Cancer of the Oral Cavity, Oropharynx and Hypopharynx. A Retrospective Analysis of 32 Cases. Journal of Chemotherapy. 3(3). 183–188. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact